Stacia Ann Smith, MD | |
1401 S Laventure Rd, Mount Vernon, WA 98274-6033 | |
(360) 424-2400 | |
(360) 424-2418 |
Full Name | Stacia Ann Smith |
---|---|
Gender | Female |
Speciality | Orthopedic Surgery |
Experience | 37 Years |
Location | 1401 S Laventure Rd, Mount Vernon, Washington |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1295734499 | NPI | - | NPPES |
44444 | Other | WA | LABOR AND INDUSTRIES |
8148363 | Medicaid | WA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | MD00029938 (Washington) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Island Hospital | Anacortes, WA | Hospital |
Peacehealth Peace Island Medical Center | Friday harbor, WA | Hospital |
Whidbeyhealth Medical Center | Coupeville, WA | Hospital |
Skagit Valley Hospital | Mount vernon, WA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Proliance Surgeons Inc Ps | 8527972900 | 388 |
News Archive
Population Genetics Technologies Ltd., creator of innovative methods for genetic analyses and biomarker discovery, has successfully completed a pilot study to prove that its GenomePooling™ method is sensitive and accurate enough to detect even small percentages of gene variants within cancer tissue.
Maxim Pharmaceuticals today announced that its treatment protocol to provide its investigational drug Ceplene(TM), in combination with interleukin-2 (IL-2), for the treatment of patients with advanced malignant melanoma, has been approved by the U.S. Food and Drug Administration (FDA).
A genetically modified poliovirus therapy developed at Duke Cancer Institute shows significantly improved long-term survival for patients with recurrent glioblastoma, with a three-year survival rate of 21 percent in a phase 1 clinical trial.
Members of the Springfield community turned out in force to support the comprehensive treatment services provided to adults and teens by Gateway Foundation's Alcohol and Drug Rehab's Springfield Treatment Center at an April 14 Open House.
› Verified 1 days ago
Entity Name | Proliance Surgeons Inc Ps |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1023170313 PECOS PAC ID: 8527972900 Enrollment ID: O20031119000128 |
News Archive
Population Genetics Technologies Ltd., creator of innovative methods for genetic analyses and biomarker discovery, has successfully completed a pilot study to prove that its GenomePooling™ method is sensitive and accurate enough to detect even small percentages of gene variants within cancer tissue.
Maxim Pharmaceuticals today announced that its treatment protocol to provide its investigational drug Ceplene(TM), in combination with interleukin-2 (IL-2), for the treatment of patients with advanced malignant melanoma, has been approved by the U.S. Food and Drug Administration (FDA).
A genetically modified poliovirus therapy developed at Duke Cancer Institute shows significantly improved long-term survival for patients with recurrent glioblastoma, with a three-year survival rate of 21 percent in a phase 1 clinical trial.
Members of the Springfield community turned out in force to support the comprehensive treatment services provided to adults and teens by Gateway Foundation's Alcohol and Drug Rehab's Springfield Treatment Center at an April 14 Open House.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Stacia Ann Smith, MD 805 Madison St, Suite 901, Seattle, WA 98104-1172 Ph: (206) 264-8100 | Stacia Ann Smith, MD 1401 S Laventure Rd, Mount Vernon, WA 98274-6033 Ph: (360) 424-2400 |
News Archive
Population Genetics Technologies Ltd., creator of innovative methods for genetic analyses and biomarker discovery, has successfully completed a pilot study to prove that its GenomePooling™ method is sensitive and accurate enough to detect even small percentages of gene variants within cancer tissue.
Maxim Pharmaceuticals today announced that its treatment protocol to provide its investigational drug Ceplene(TM), in combination with interleukin-2 (IL-2), for the treatment of patients with advanced malignant melanoma, has been approved by the U.S. Food and Drug Administration (FDA).
A genetically modified poliovirus therapy developed at Duke Cancer Institute shows significantly improved long-term survival for patients with recurrent glioblastoma, with a three-year survival rate of 21 percent in a phase 1 clinical trial.
Members of the Springfield community turned out in force to support the comprehensive treatment services provided to adults and teens by Gateway Foundation's Alcohol and Drug Rehab's Springfield Treatment Center at an April 14 Open House.
› Verified 1 days ago
Farouq A Al-hamdan, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 119 S 14th St, Mount Vernon, WA 98274 Phone: 713-553-3944 | |
David Michael Mourning, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2320 Freeway Dr, Mount Vernon, WA 98273 Phone: 360-814-6800 Fax: 360-814-6953 | |
Camille Lauren Connelly, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1500 Continental Pl, Mount Vernon, WA 98273 Phone: 360-424-7041 Fax: 360-424-2456 | |
Michael J. Picco, DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2320 Freeway Drive, Mount Vernon, WA 98237 Phone: 360-814-6800 Fax: 360-814-6917 | |
Dr. Michael Ge Thomas, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2320 Freeway Drive, Mount Vernon, WA 98273 Phone: 360-814-6800 Fax: 360-814-6917 | |
Robert M. Lipscomb, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2320 Freeway Dr, Mount Vernon, WA 98273 Phone: 360-814-6800 Fax: 360-814-6917 |